DrugPatentWatch Database Preview
Ferric derisomaltose - Generic Drug Details
What are the generic sources for ferric derisomaltose and what is the scope of patent protection?
Ferric derisomaltose
is the generic ingredient in one branded drug marketed by Pharmacosmos As and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.Ferric derisomaltose has forty patent family members in twenty-five countries.
There are twenty drug master file entries for ferric derisomaltose.
Summary for ferric derisomaltose
| International Patents: | 40 |
| US Patents: | 2 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 20 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| Clinical Trials: | 4 |
| What excipients (inactive ingredients) are in ferric derisomaltose? | ferric derisomaltose excipients list |
| DailyMed Link: | ferric derisomaltose at DailyMed |
Recent Clinical Trials for ferric derisomaltose
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | Phase 4 |
| National Institutes of Health (NIH) | Phase 4 |
| Massachusetts General Hospital | Phase 4 |
US Patents and Regulatory Information for ferric derisomaltose
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacosmos As | MONOFERRIC | ferric derisomaltose | SOLUTION;INTRAVENOUS | 208171-001 | Jan 16, 2020 | DISCN | Yes | No | ⤷ Try it Free | ⤷ Try it Free | Y | Y | ⤷ Try it Free | ||
| Pharmacosmos As | MONOFERRIC | ferric derisomaltose | SOLUTION;INTRAVENOUS | 208171-003 | Jan 16, 2020 | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | Y | Y | ⤷ Try it Free | ||
| Pharmacosmos As | MONOFERRIC | ferric derisomaltose | SOLUTION;INTRAVENOUS | 208171-002 | Jan 16, 2020 | DISCN | Yes | No | ⤷ Try it Free | ⤷ Try it Free | Y | Y | ⤷ Try it Free | ||
| Pharmacosmos As | MONOFERRIC | ferric derisomaltose | SOLUTION;INTRAVENOUS | 208171-003 | Jan 16, 2020 | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | Y | Y | ⤷ Try it Free | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ferric derisomaltose
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Eurasian Patent Organization | 023917 | ⤷ Try it Free |
| Brazil | PI0924653 | ⤷ Try it Free |
| European Patent Office | 3821910 | ⤷ Try it Free |
| Slovenia | 3156075 | ⤷ Try it Free |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for ferric derisomaltose
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2411053 | C02411053/01 | Switzerland | ⤷ Try it Free | PRODUCT NAME: FERRUM (III) UT FERRI ISOMALTOSIDUM; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 67001 26.08.2019 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
